Based upon the surface under cumulative ranking curve, incretin mimetics were the most effective treatment in reducing the rates of hypoglycemia in T2DM patients fasting during Ramadan, followed by insulin glargine, meglitinides, and finally SU (Supplementary Figure 1). The gene discussed is INS; the disease is Hypoglycemia.